Search Results - "Viiklepp, Piret"

Mortality in adults with multidrug-resistant tuberculosis and HIV by antiretroviral therapy and tuberculosis drug use: an individual patient data meta-analysis by Bisson, Gregory P, Bastos, Mayara, Campbell, Jonathon R, Bang, Didi, Brust, James C, Isaakidis, Petros, Lange, Christoph, Menzies, Dick, Migliori, Giovanni B, Pape, Jean W, Palmero, Domingo, Baghaei, Parvaneh, Tabarsi, Payam, Viiklepp, Piret, Vilbrun, Stalz, Walsh, Jonathan, Marks, Suzanne M

“…HIV-infection is associated with increased mortality during multidrug-resistant tuberculosis treatment, but the extent to which the use of antiretroviral…”
Get full text

Aminoglycosides and Capreomycin in the Treatment of Multidrug-resistant Tuberculosis: Individual Patient Data Meta-analysis of 12 030 Patients From 25 Countries, 2009–2016 by Cegielski, J Peter, Chan, Pei-Chun, Lan, Zhiyi, Udwadia, Zarir F, Viiklepp, Piret, Yim, Jae-Joon, Menzies, Dick

“…Abstract Background As new drugs are developed for multidrug-resistant tuberculosis (MDR-TB), the role of currently used drugs must be reevaluated. Methods We…”
Get full text

Estimating treatment importance in multidrug‐resistant tuberculosis using Targeted Learning: An observational individual patient data network meta‐analysis by Wang, Guanbo, Schnitzer, Mireille E., Menzies, Dick, Viiklepp, Piret, Holtz, Timothy H., Benedetti, Andrea

“…Persons with multidrug‐resistant tuberculosis (MDR‐TB) have a disease resulting from a strain of tuberculosis (TB) that does not respond to at least isoniazid…”
Get full text

Spatiotemporal dynamics of drug‐resistant Mycobacterium tuberculosis: Contrasting trends and implications for tuberculosis control in EU high‐priority country by Mokrousov, Igor, Vyazovaya, Anna, Levina, Klavdia, Gerasimova, Alena, Zhuravlev, Viacheslav, Viiklepp, Piret, Kütt, Marge

“…Different and contrasting trends related to human migration and the implementation of health control programmes influence the spread of drug‐resistant…”
Get full text

Treatment Outcomes in Multidrug-Resistant Tuberculosis by Günther, Gunar, Lange, Christoph, Alexandru, Sofia, Altet, Neus, Avsar, Korkut, Bang, Didi, Barbuta, Raisa, Bothamley, Graham, Ciobanu, Ana, Crudu, Valeriu, Danilovits, Manfred, Dedicoat, Martin, Duarte, Raquel, Gualano, Gina, Kunst, Heinke, de Lange, Wiel, Leimane, Vaira, Magis-Escurra, Cecile, McLaughlin, Anne-Marie, Muylle, Inge, Polcová, Veronika, Popa, Christina, Rumetshofer, Rudolf, Skrahina, Alena, Solodovnikova, Varvara, Spinu, Victor, Tiberi, Simon, Viiklepp, Piret, van Leth, Frank

“…Multidrug-resistant tuberculosis is a major global challenge. This report examines the definition of treatment success and its effect on determining cure. To…”
Get full text

Evaluating the performance of propensity score matching based approaches in individual patient data meta-analysis by Johara, Fatema Tuj, Benedetti, Andrea, Platt, Robert, Menzies, Dick, Viiklepp, Piret, Schaaf, Simon, Chan, Edward

“…Individual-patient data meta-analysis (IPD-MA) is an increasingly popular approach because of its analytical benefits. IPD-MA of observational studies must…”
Get full text

Modeling treatment effect modification in multidrug-resistant tuberculosis in an individual patientdata meta-analysis by Liu, Yan, Schnitzer, Mireille E, Wang, Guanbo, Kennedy, Edward, Viiklepp, Piret, Vargas, Mario H, Sotgiu, Giovanni, Menzies, Dick, Benedetti, Andrea

“…Effect modification occurs while the effect of the treatment is not homogeneous across the different strata of patient characteristics. When the effect of…”
Get full text

Surgery as an Adjunctive Treatment for Multidrug-Resistant Tuberculosis: An Individual Patient Data Metaanalysis by Fox, Gregory J., Mitnick, Carole D., Benedetti, Andrea, Chan, Edward D., Becerra, Mercedes, Chiang, Chen-Yuan, Keshavjee, Salmaan, Koh, Won-Jung, Shiraishi, Yuji, Viiklepp, Piret, Yim, Jae-Joon, Pasvol, Geoffrey, Robert, Jerome, Shim, Tae Sun, Shin, Sonya S., Menzies, Dick

“…Background. Medical treatment for multidrug-resistant (MDR)-tuberculosis is complex, toxic, and associated with poor outcomes. Surgical lung resection may be…”
Get full text

A successful introduction to a non-expert setting of the thin-layer agar Colour Test as an indirect phenotypic drug susceptibility test for Mycobacterium tuberculosis by Klaos, Kadri, Agejeva, Anna, Kummik, Tiina, Laks, Sirje, Remets, Olesja, Sasi, Sirje, Tann, Anneli, Viiklepp, Piret, Altraja, Alan

“…•Results from the thin-layer agar MDR/XDR-TB Colour Test are highly reproducible.•Implementation of the thin-layer agar Colour Test does not require skilled…”
Get full text

Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies by Kurbatova, Ekaterina V, Dr, Cegielski, J Peter, MD, Lienhardt, Christian, PhD, Akksilp, Rattanawadee, BSc, Bayona, Jaime, MD, Becerra, Mercedes C, ScD, Caoili, Janice, MD, Contreras, Carmen, BA, Dalton, Tracy, PhD, Danilovits, Manfred, MD, Demikhova, Olga V, Prof, Ershova, Julia, PhD, Gammino, Victoria M, PhD, Gelmanova, Irina, MD, Heilig, Charles M, PhD, Jou, Ruwen, Prof, Kazennyy, Boris, MD, Keshavjee, Salmaan, MD, Kim, Hee Jin, MD, Kliiman, Kai, PhD, Kvasnovsky, Charlotte, MD, Leimane, Vaira, MD, Mitnick, Carole D, ScD, Quelapio, Imelda, MD, Riekstina, Vija, MD, Smith, Sarah E, MPH, Tupasi, Thelma, MD, van der Walt, Martie, PhD, Vasilyeva, Irina A, Prof, Via, Laura E, PhD, Viiklepp, Piret, MD, Volchenkov, Grigory, MD, Walker, Allison Taylor, PhD, Wolfgang, Melanie, MPH, Yagui, Martin, MD, Zignol, Matteo, MD

“…Summary Background Sputum culture conversion is often used as an early microbiological endpoint in phase 2 clinical trials of tuberculosis treatment on the…”
Get full text

Treatment outcomes of MDR-TB and HIV co-infection in Europe by Magis-Escurra, Cecile, Günther, Gunar, Lange, Christoph, Alexandru, Sofia, Altet, Neus, Avsar, Korkut, Bang, Didi, Barbuta, Raisa, Bothamley, Graham, Ciobanu, Ana, Crudu, Valeriu, Davilovits, Manfred, Dedicoat, Martin, Duarte, Raquel, Gualano, Gina, Kunst, Heike, de Lange, Wiel, Leimane, Vaira, McLaughlin, Anne-Marie, Muylle, Inge, Polcová, Veronika, Popa, Christina, Rumetshofer, Rudolf, Skrahina, Alena, Solodovnikova, Varvara, Spinu, Victor, Tiberi, Simon, Viiklepp, Piret, van Leth, Frank

“…The ongoing HIV epidemic and the increasing number of patients with drug-resistant tuberculosis (TB) are seriously hampering global TB-control activities,…”
Get full text

Group 5 drugs for multidrug-resistant tuberculosis: individual patient data meta-analysis by Fox, Greg J, Benedetti, Andrea, Cox, Helen, Koh, Won-Jung, Viiklepp, Piret, Ahuja, Shama, Pasvol, Geoffrey, Menzies, Dick

“…The role of so-called "group 5" second-line drugs as a part of antibiotic therapy for multidrug-resistant tuberculosis (MDR-TB) is widely debated. We performed…”
Get full text

Drug Susceptibility Patterns in MDR-TB Patients: Challenges for Future Regimen Design. A Cross-Sectional Study by Stagg, Helen R, Brown, James, Ibraim, Elmira, Riekstiņa, Vija, Viiklepp, Piret, Cīrule, Andra, Cocei, Horia, Danilovitš, Manfred, Dravniece, Gunta, Jackson, Charlotte, White, Peter J

“…Globally, there is substantial concern regarding the challenges of treating complex drug resistance patterns in multidrug resistant tuberculosis cases…”
Get full text

Correction to: Reply to van Deun and Decroo by Cegielski, J P Peter, Udwadia, Zarir F, Viiklepp, Piret, Yim, Jae-Joon, Menzies, Dick

Get full text

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis by Ahmad, Nafees, Ahuja, Shama D, Akkerman, Onno W, Alffenaar, Jan-Willem C, Anderson, Laura F, Bang, Didi, Barry, Pennan M, Bastos, Mayara L, Behera, Digamber, Benedetti, Andrea, Bisson, Gregory P, Boeree, Martin J, Bonnet, Maryline, Brode, Sarah K, Brust, James C M, Cai, Ying, Caumes, Eric, Cegielski, J Peter, Centis, Rosella, Chan, Pei-Chun, Chang, Kwok-Chiu, Charles, Macarthur, Cirule, Andra, Dalcolmo, Margareth Pretti, D'Ambrosio, Lia, de Vries, Gerard, Dheda, Keertan, Esmail, Aliasgar, Flood, Jennifer, Fox, Gregory J, Fréchet-Jachym, Mathilde, Fregona, Geisa, Gayoso, Regina, Gegia, Medea, Gler, Maria Tarcela, Gu, Sue, Guglielmetti, Lorenzo, Holtz, Timothy H, Hughes, Jennifer, Jarlsberg, Leah, Kempker, Russell R, Keshavjee, Salmaan, Kipiani, Maia, Koenig, Serena P, Koh, Won-Jung, Kritski, Afranio, Kuksa, Liga, Kvasnovsky, Charlotte L, Lan, Zhiyi, Lange, Christoph, Laniado-Laborín, Rafael, Lee, Myungsun, Leung, Chi-Chiu, Leung, Eric Chung-Ching, Li, Pei Zhi, Lowenthal, Phil, Maciel, Ethel L, Marks, Suzanne M, Mase, Sundari, Mbuagbaw, Lawrence, Migliori, Giovanni B, Milanov, Vladimir, Miller, Ann C, Mitnick, Carole D, Modongo, Chawangwa, Mohr, Erika, Monedero, Ignacio, Nahid, Payam, Ndjeka, Norbert, O'Donnell, Max R, Padayatchi, Nesri, Palmero, Domingo, Pape, Jean William, Podewils, Laura J, Reynolds, Ian, Riekstina, Vija, Robert, Jérôme, Rodriguez, Maria, Seung, Kwonjune J, Schnippel, Kathryn, Shim, Tae Sun, Singla, Rupak, Smith, Sarah E, Sotgiu, Giovanni, Sukhbaatar, Ganzaya, Tabarsi, Payam, Tiberi, Simon, Trieu, Lisa, Udwadia, Zarir F, van der Werf, Tjip S, Veziris, Nicolas, Viiklepp, Piret, Vilbrun, Stalz Charles, Walsh, Kathleen, Westenhouse, Janice, Yew, Wing-Wai, Yim, Jae-Joon, Zetola, Nicola M, Zignol, Matteo, Menzies, Dick

“…Treatment outcomes for multidrug-resistant tuberculosis remain poor. We aimed to estimate the association of treatment success and death with the use of…”
Get full text

Low Body Mass Index at Treatment Initiation and Rifampicin-Resistant Tuberculosis Treatment Outcomes: An Individual Participant Data Meta-Analysis by Campbell, Jonathon R, Chan, Edward D, Falzon, Dennis, Trajman, Anete, Keshavjee, Salmaan, Leung, Chi C, Miller, Ann C, Monedero-Recuero, Ignacio, Rodrigues, Denise S, Seo, Haesook, Baghaei, Parvaneh, Udwadia, Zarir, Viiklepp, Piret, Bastos, Mayara, Menzies, Dick

“…Abstract Background The impact of low body mass index (BMI) at initiation of rifampicin-resistant tuberculosis (RR-TB) treatment on outcomes is uncertain. We…”
Get full text

Reply to van Deun and Decroo by Cegielski, J Peter, Udwadia, Zarir F, Viiklepp, Piret, Yim, Jae-Joon, Menzies, Dick

Get full text

Emerging resistant clones of Mycobacterium tuberculosis in a spatiotemporal context by Vyazovaya, Anna, Levina, Klavdia, Zhuravlev, Viacheslav, Viiklepp, Piret, Kütt, Marge, Mokrousov, Igor

“…We assessed the genetic structure of the Mycobacterium tuberculosis population in Estonia with a special focus on major epidemic/endemic clones and drug…”
Get full text

National lung cancer screening program feasibility study in Estonia by Kallavus, Kadi, Laisaar, Kaja-Triin, Rätsep, Anneli, Kiudma, Tarvo, Takker, Urmas, Poola, Anneli, Makke, Vahur, Frik, Marianna, Viiklepp, Piret, Taur, Merily, Laisaar, Tanel

“…Abstract OBJECTIVES The main aim of the lung cancer screening (LCS) feasibility study was to investigate the plausibility of and bottlenecks to systematic…”
Get full text

Tuberculosis elimination: theory and practice in Europe by D'AMBROSIO, Lia, DARA, Masoud, BLASI, Francesco, MIGLIORI, Giovanni Battista, TADOLINI, Marina, CENTIS, Rosella, SOTGII, Giovanni, VAN DER WERF, Marieke J, GAGA, Mina, CIRILLO, Daniela, SPANEVELLO, Antonio, RAVIGLIONE, Mario

“…Although Europe identified the pathway to tuberculosis (TB) elimination in 1990, no information on programmes for country preparedness is available. A…”
Get full text